Ligand Pharmaceuticals

NASDAQ: LGND · Real-Time Price · USD
150.89
-2.90 (-1.89%)
At close: Aug 15, 2025, 3:59 PM
151.08
0.13%
After-hours: Aug 15, 2025, 04:10 PM EDT

Ligand Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-42.45M -31.09M -7.17M -51.91M 86.14M 18.19M -10.27M 2.29M 41.95M -17.48M 404K -895K -15.38M -5.42M 13.72M 30.73M 18.11M
Depreciation & Amortization
9.34M 8.63M 7.29M 9.36M 9.24M 8.92M 8.54M 9.06M 9.12M 11.13M 13.51M 13.09M 13.64M 12.95M 12.61M 12.29M 13.09M
Stock-Based Compensation
7.84M 7.52M 26.23M 11.06M 7.33M 5.72M 6.88M 7.21M 5.93M 29.14M 12.6M 9.5M 9.04M 10.41M 9.75M 10.22M 8.4M
Other Working Capital
-1.94M 3.42M -9.59M -2.82M 3.53M -21.37M -10.73M 10.67M 5.2M -6.21M 2.75M -3.8M 9.31M 5.6M -13.68M -11.48M -8.39M
Other Non-Cash Items
13.84M 44.5M 12.8M 107.59M -90.71M -13.71M 15.32M -3.16M -39.7M -42.19M 1.62M 3.12M 10.61M 19.26M -3.8M -21.48M -1.26M
Deferred Income Tax
-8.84M -12.69M -1.99M -20.67M 19.55M 4.93M 8.01M -10M 8.75M 46.29M -12.64M 3.25M -16.18M -389K 1.54M 2.64M -12.41M
Change in Working Capital
-5.17M 11.6M -633K -7.61M 8.24M -15.99M -20.83M -5.48M 7.9M 26.57M 5.01M -16.19M 50.28M -9.16M -13.81M -14.01M -15.18M
Operating Cash Flow
-25.45M 28.47M 36.53M 13.26M 18.69M 8.06M 7.65M -82K 33.95M 53.47M 20.49M 11.88M 52.01M 27.64M 20.02M 20.38M 10.75M
Capital Expenditures
-214K -712K -14.24M -2.14M -105K -50.74M -487K -203K -2.41M -1.17M -5.29M -6.59M -4.88M -2.19M -1.77M -4.79M -3.4M
Cash Acquisitions
n/a 80.19M -96.19M -75M -998K -14K -25.64M n/a n/a n/a n/a n/a -750K 494K n/a n/a n/a
Purchase of Investments
-59.37M -96.95M -4.77M -24.44M -77.63M -19.5M -18.27M -49.13M -39.86M -12.17M -580K -282K -38.19M -64.43M -20.76M -23.99M -72.15M
Sales Maturities Of Investments
70.77M 45.18M 94.8M 47.06M 75.46M 59.91M 24.76M 56.8M 52.7M 7.01M 25M 44.69M 157.7M 31.77M 4.32M 44.34M 140.91M
Other Investing Acitivies
-6.29M -66.34M -43.92M -75.23M -501K 69K 136K 83K 130K -948K 47K 33K 118.76M -1.35M -16.45M -1.01M -3.64M
Investing Cash Flow
4.89M -38.62M -46.51M -54.76M -3.77M -10.28M -19.5M 7.56M 10.55M -7.28M 19.18M 37.85M 113.88M -35.71M -18.22M 19.34M 65.11M
Debt Repayment
-7K -6K -10K -4K -5K n/a 26K -76.87M -13K -12K -37.65M -59.93M -163.37M n/a -2.38M -49.95M -112.62M
Common Stock Repurchased
n/a n/a n/a n/a -3.08M -257K -103K -32K n/a -2.22M -96K -60K -5.86M -18.45M -2K n/a -5.9M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-8.96M 17.28M 33.7M 9.49M 12.19M 5.57M 3.24M 9.11M n/a -5.29M -3.09M 492K -7.05M 4.16M 1.99M 41K 20.99M
Financial Cash Flow
-4.75M 20.39M 55.08M 9.55M 12.22M 5.32M 3.27M -67.76M -775K -5.3M -40.83M -59.44M -170.42M 4.16M -385K -49.91M -91.64M
Net Cash Flow
-24.32M 8.69M 45.48M -31.95M 27.14M 3.1M -8.59M -60.28M 43.72M 40.89M -1.16M -9.71M -4.53M -3.91M 1.42M -10.19M -15.77M
Free Cash Flow
-25.66M 27.76M 22.29M 11.12M 18.59M -42.68M 7.16M -285K 31.53M 52.3M 15.2M 5.29M 47.14M 25.45M 18.25M 15.58M 7.35M